AzTrials
AzTrials

Alcohol MisuseNCT07414589

Brief Alcohol Treatment for Women Veterans in Primary Care

A study testing Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care in people with Alcohol Misuse, run by Syracuse VA Medical Center at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to develop and test a brief behavioral treatment for women Veterans with alcohol use in primary care. The study involves a development phase, an open trial phase, and a pilot randomized controlled trial. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Alcohol Misuse
What is being tested?
Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteUnited States
Study dates
Oct 2026to Aug 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Veteran status
  • past-year Syracuse VAMC or community-based outpatient clinic (CBOC) primary care appointment
  • identify as woman OR use women's PC services
  • unhealthy alcohol use (AUDIT ≥ 7)

Who cannot join

  • current substance use treatment outside PC
  • current psychosis, mania, or dementia (>10 on the BOMC)
  • need for a higher level of alcohol or substance use care (detoxification, residential treatment) as indicated by a) patient preference b) withdrawal symptoms that indicate a need to monitor (≥23 on the AWSC) or high risk substance use (≥27 on the ASSIST)
  • imminent risk of suicide.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Katherine A Buckheit, PhD contact

315-425-4400 ext. 56742

katheirne.buckheit@va.gov

United States1 site
  • Syracuse VA Medical Center

    Syracuse, New York, 13210

    Katherine A Buckheit, PhD, 315-425-4400 ext. 56742, katherine.buckheit@va.gov

    Katherine A Buckheit, PhD

Other trials in United States

About this study

Official title: A Brief, Integrated Intervention for Women Veterans With Unhealthy Alcohol Use in Primary Care

The goal of this study is to develop and test a brief behavioral treatment for women Veterans with alcohol use in primary care. The study involves a development phase, an open trial phase, and a pilot randomized controlled trial. The main questions it aims to answer are:

  • Is the treatment feasible and acceptable to women Veteran primary care patients?
  • Can the treatment help reduce alcohol use, alcohol-related problems, and improve quality of life? Researchers will compare the new treatment to usual treatment that primary care patients would normally receive. Participants will be asked to participate in either the new behavioral treatment or usual primary care treatment and attend 3 appointments to answer questions about their alcohol use, quality of life, other mental health symptoms, and what they thought of their behavioral treatment.
Conditions
Alcohol Misuse
Being tested
Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care, Primary care usual care
Keywords
alcohol, integrated primary care, women Veterans

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary CareBehavioural

    The intervention consists of 4-6 30-minute behavioral health appointments with a behavioral health provider in an integrated primary care setting. It includes 4 core alcohol-focused appointments focused on providing information and skills to manage unhealthy alcohol use that have been adapted from existing evidence-based treatments in integrated primary care and specialty care. Participants may elect to attend up to 2 additional optional appointments focused on supplemental strategies to manage alcohol use or to address co-occurring mental and behavioral health concerns, including mood, trauma, sleep, and pain.

  • Primary care usual careBehavioural

    Primary care usual care consists of universal annual alcohol screening; those who are identified as at-risk receive a brief advice intervention from their primary care provider and may be offered an integrated primary care referral. The brief advice intervention is standardized and triggered automatically by a positive screen. Integrated primary care consists of brief assessment and intervention with licensed, independent behavioral health providers. Patients may decline integrated primary care referrals, complete several appointments, and/or be referred to specialty treatment

Study groups in NCT07414589
Study groupRoleWhat they receive
Brief intervention for unhealthy alcohol useExperimentalParticipants in this arm will attend 4-6 30-minute behavioral health appointments with a behavioral health provider in an integrated primary care setting. All participants will attend 4 core alcohol-focused appointments focused on providing information and skills to manage unhealthy alcohol use. Participants may elect to attend up to 2 additional optional appointments focused on supplemental strategies to manage alcohol use or to address co-occurring mental and behavioral health concerns.
Receives: Behavioral: Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care
Usual CareActive comparatorPrimary care usual care consists of universal annual alcohol screening; those who are identified as at-risk receive a brief advice intervention from their primary care provider and may be offered an integrated primary care referral. The brief advice intervention is standardized and triggered automatically by a positive screen. Integrated primary care consists of brief assessment and intervention with licensed, independent behavioral health providers. Patients may decline integrated primary care referrals, complete several appointments, and/or be referred to specialty treatment
Receives: Behavioral: Primary care usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in self-reported quality of life from baseline to 6-months post-treatment

    Quality of life will be assessed by the abbreviated World Health Organization Quality of Life Assessment (WHOQOL-BREF), a 26-item self-report measure of QoL in the past 2 weeks in 4 areas (social, physical, psychological, and environment) on a 1-5 scale.

    Measured: From baseline to 6 months post-treatment

  2. Change in self-reported alcohol-related problems from baseline to 6 months post-treatment

    Alcohol problems will be assessed by the Short Inventory of Problems-Revised (SIP-R)147, a 17-item self-report measure of frequency of alcohol problems on a 0-3 scale.

    Measured: From baseline to 6 months post-treatment

  3. Change in self-reported alcohol-related functional impairment from baseline to 6 months post-treatment

    Alcohol-specific functional impairment will be assessed by the Addiction Severity Index - Lite, a semi-structured interview developed among Veterans in substance use treatment that assesses alcohol and drug use and problems and 5 areas of functioning: medical, legal, psychiatric, employment, and family/social

    Measured: Baseline to 6 months post-treatment

  4. Feasibility - average session length

    Length of sessions in the experimental condition will be measured to test if the average is within guidelines for integrated primary care treatment (30 minutes maximum).

    Measured: For the duration of the intervention period, 8-12 weeks post-baseline.

  5. Intervention fidelity

    An independent rater will listen to session tapes and record if each essential element was delivered on a checklist.

    Measured: For the duration of the intervention period, 8-12 weeks post-baseline.

  6. Self-reported patient acceptability of the experimental intervention

    Patient acceptability will be assessed with the Client Satisfaction Questionnaire (CSQ), an 8-item self-report measure. Acceptability ratings of at least "moderate" on the majority (5/8) of items on the CSQ will be considered acceptable.

    Measured: After completing the behavioral health treatment, 8-12 weeks post-baseline.

Secondary outcomes (1)
  1. Self-reported change in alcohol consumption from baseline to 6 months post-treatment

    Alcohol use will be assessed with the Timeline Followback (TLFB), a calendar-based measure that records standard drinks consumed each day in the past month to yield percent of drinking days, average drinks per drinking day, percent of heavy drinking (i.e., ≥4 drinks/occasion) days, and a variable indicating if alcohol use is above NIAAA-recommendations.

    Measured: Baseline to 6 months post-treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2026
  2. Study startOct 2026 (estimated)
  3. Primary completionSep 2028 (estimated)
  4. Study completionAug 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07414589
Sponsor's protocol ID
1825686
Other IDs
K01AA031524-01A1
Status last verified
Feb 2026
First submitted
3 Feb 2026
Last updated
17 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Once all data collection is complete and the coded database is finalized, IPD will be shared according to PI discretion. For instance, IPD may be shared to be used in meta-analyses or other review papers. No identifiable participant information will be shared.

Questions about this trial

What is this clinical trial studying?

A study testing Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care in people with Alcohol Misuse, run by Syracuse VA Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 17 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Katherine A Buckheit, PhD (315-425-4400 ext. 56742, katheirne.buckheit@va.gov), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in self-reported quality of life from baseline to 6-months post-treatment (time frame: From baseline to 6 months post-treatment). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in